Cue Health (HLTH)
(Delayed Data from NSDQ)
$0.14 USD
0.00 (-3.09%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.14 0.00 (-0.71%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Income Statements
Fiscal Year end for Cue Health Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 71 | 483 | 618 | 23 | 7 |
Cost Of Goods | 127 | 330 | 277 | 15 | 0 |
Gross Profit | -56 | 154 | 342 | 8 | 7 |
Selling & Adminstrative & Depr. & Amort Expenses | 339 | 359 | 151 | 53 | 27 |
Income After Depreciation & Amortization | -395 | -206 | 190 | -45 | -21 |
Non-Operating Income | 27 | 2 | -61 | -2 | 0 |
Interest Expense | 1 | 1 | 10 | 0 | 0 |
Pretax Income | -369 | -204 | 119 | -47 | -21 |
Income Taxes | 5 | -10 | 33 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -373 | -194 | 86 | -47 | -21 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -373 | -194 | 86 | -47 | -21 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -339 | -161 | 223 | -39 | -17 |
Depreciation & Amortization (Cash Flow) | 56 | 45 | 33 | 6 | 4 |
Income After Depreciation & Amortization | -395 | -206 | 190 | -45 | -21 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 152.88 | 148.03 | 59.64 | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.75 | -1.29 | 1.21 | NA | NA |
Diluted Net EPS (GAAP) | -2.44 | -1.31 | 0.59 | NA | NA |
Fiscal Year end for Cue Health Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 18.80 | 17.48 | 9.90 | 24.77 |
Cost Of Goods | NA | 35.74 | 22.18 | 29.35 | 39.82 |
Gross Profit | NA | -16.94 | -4.70 | -19.45 | -15.06 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 48.32 | 60.00 | 65.95 | 80.79 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -65.26 | -64.70 | -85.40 | -95.85 |
Non-Operating Income | NA | -5.36 | 22.77 | 1.82 | 1.87 |
Interest Expense | NA | 0.34 | 0.30 | 0.29 | 0.22 |
Pretax Income | NA | -148.37 | -42.24 | -83.86 | -94.20 |
Income Taxes | NA | 0.06 | 4.73 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -148.43 | -46.97 | -83.86 | -94.20 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -148.43 | -46.97 | -83.86 | -94.20 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 154.81 | 153.70 | 151.87 | 151.08 |
Diluted EPS Before Non-Recurring Items | NA | -0.32 | -0.42 | -0.51 | -0.48 |
Diluted Net EPS (GAAP) | NA | -0.96 | -0.31 | -0.55 | -0.62 |